Product Name | NebuSelect™ Recombinant Human VEGF-C/Flt4-L, Avi-His-tag |
---|---|
Catalog Number | NBL-240703 |
Alias/Synonyms | VEGF-C/Flt4-L; VEGFC; VEGFc; Flt4-L; VRP; VEGF-C |
Appearance | see COA |
Molecule Weight | Thr103-Arg227 |
CAS | N/A |
Solubility | Water Soluble |
Storage | Short term 4℃; Long term -20℃. |
Shelf Life | 2 years |
Additional info 1 | Q6FH59 |
Additional info 2 |
Catalog Numbe | Size | Price | Inventory Level | |
NBL-240703-100ug | 100ug | Inquire | Inquire | |
NBL-240703-1mg | 1mg | Inquire | Inquire | |
NBL-240703-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human VEGF-C/Flt4-L, Avi-His-tag
Catalog#:
NBL-240703
Description:
NebuSelect™ Recombinant Human VEGF-C/Flt4-L, Avi-His-tag(Cat#NBL-240703) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Thr103-Arg227.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 17.1 kDa. Due to glycosylation, the protein migrates to 23-30 kDa based on Bis-Tris PAGE result.
Target Name:
VEGF-C/Flt4-L; VEGFC; VEGFc; Flt4-L; VRP; VEGF-C
Target Information:
the lymphangiogenic factors vascular endothelial growth factor C (VEGFC) and VEGFD are cleaved by thrombin and plasmin, serine proteases generated during hemostasis and wound healing. Genetic studies reveal that platelet enhancement of lymphatic growth after wounding is dependent on the release of VEGFC, but not VEGFD, a finding consistent with high expression of VEGFC in both platelets and avian thrombocytes.
Amino Acid Sequence:
Thr103-Arg227
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.